• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Medical Marijuana, Inc. Investment AXIM Biotechnologies Files Intellectual Property Application for THC Extraction Method


AXIM Biotechnologies, Inc. (OTC:AXIM) announced today that they have filed an intellectual property (IP) application with the World Intellectual Property Organization (WIPO) for a highly complex method of THC extraction. Tetrahydrocannabinol, or THC, is the valuable psychoactive cannabinoid present in cannabis plants. Once extracted, it can be turned into a variety of high margin cannabis derived products like tinctures and more.


AXIM won't be making tinctures with it, but rather begin developments of "novel and revolutionary drug products," according to Medical Marijuana, Inc. (OTC:MJNA) CEO DR. Stuart Titus.  AXIM believes that this method can produce THC extract with a higher purity than conventional methods being used today.


MJNA Investment


AXIM Biotechnologies, Inc. is 45.5% owned by Medical Marijuana, Inc. according to a recent MJNA research report published by StoneBridge Partners. This gives interested investors two different ways of gaining exposure to AXIM. Either a pure play investment in AXIM, or a more diversified play through MJNA. Either one is set to benefit from this valuable IP portfolio that AXIM is building. Just recently, AXIM was granted a valuable patent for cannabinoid-containing controlled-release chewing gum.


For the Chemists


According to AXIM, their THC extraction method differs from conventional methods because "a neutral metal salt or inorganic base solution saturated with the metal neutral salt and adjusted to basic pH enables separation of the THC-A layer and significantly increases the yield. THC-A is then decarboxylated in a water/ethanol solution to render THC at a purity greater than 95%."


That might not make too much sense to many, so the Figure 1 included with the IP application might help:



This intellectual property was developed in joint collaboration with Syncom B.V.. Syncom is a Netherlands-based synthesis solutions company serving the biotech and pharmaceutical industries. 




For more information on Medical Marijuana, Inc. or AXIM Biotechnologies, Inc., be sure to check out their profiles in our growing marijuana stocks database. Also, don't forget to connect with us on social media using the links to the right of this article. Be sure to subscribe to The Daily Marijuana Observer newsletter below so you never miss a marijuana stock news update. To read Medical Marijuana, Inc.'s press release regarding the IP application, click here

Read more articles tagged:

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.